LDHA and central nervous system cancer: Treatment of glioma cells with 0.1 μM siLDH-A specifically suppressed mRNA of LDH-A in HTZ-349 glioma cells to 2% of the initial levels (Figure 4A), leading to decreased levels of lactate and a parallel moderate increase of glucose (Figure S2A).